These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6312527)

  • 1. [Etiology and pathogenesis of systemic scleroderma].
    Guseva NG
    Revmatologiia (Mosk); 1983; (2):3-10. PubMed ID: 6312527
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma--pathophysiology.
    Yamamoto T
    Eur J Dermatol; 2009; 19(1):14-24. PubMed ID: 19059831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis for the pathogenesis of systemic sclerosis.
    Furst DE; Clements PJ
    J Rheumatol Suppl; 1997 May; 48():53-7. PubMed ID: 9150119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis.
    Jimenez SA; Derk CT
    Ann Intern Med; 2004 Jan; 140(1):37-50. PubMed ID: 14706971
    [No Abstract]   [Full Text] [Related]  

  • 5. Scleroderma: pathogenic factors and current management.
    Penny R
    Aust N Z J Med; 1978; 8 Suppl 1():143-8. PubMed ID: 365159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
    Yamamoto T
    Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferons and scleroderma-a new clue to understanding the pathogenesis of scleroderma?
    Coelho LF; de Oliveira JG; Kroon EG
    Immunol Lett; 2008 Jun; 118(2):110-5. PubMed ID: 18499269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Various aspects of the pathogenesis of systemic scleroderma and the role of microcirculation in the morphogenesis of joint changes in the diseases].
    Rusakova MS
    Vopr Revm; 1982; (2):68-71. PubMed ID: 7113091
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis.
    Zurita-Salinas CS; Richaud-Patin Y; Krötzsch-Gómez E; Llorente L; Alcocer-Varela J; Díaz-de-León L; Palacios-Boix A
    Rev Invest Clin; 1998; 50(2):97-104. PubMed ID: 9658927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenesis of scleroderma--evolving concepts.
    Sapadin AN; Esser AC; Fleischmajer R
    Mt Sinai J Med; 2001; 68(4-5):233-42. PubMed ID: 11514910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current state of the problem of pathogenesis of systemic scleroderma].
    Rassokhina PP; Lebedev DA; Panasiuk AF; Grozdova MD; Iakovleva GI
    Ter Arkh; 1979; 51(7):114-8. PubMed ID: 494076
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Biochem Biophys Res Commun; 2006 May; 343(3):904-9. PubMed ID: 16564026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune dysfunction and the pathogenesis of scleroderma.
    Jiménez SA
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):104-13. PubMed ID: 6353581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of skin scleroderma--literature review].
    Wojas-Pelc A; Lipko-Godlewska S
    Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?
    Brinckmann J; Kim S; Wu J; Reinhardt DP; Batmunkh C; Metzen E; Notbohm H; Bank RA; Krieg T; Hunzelmann N
    Matrix Biol; 2005 Oct; 24(7):459-68. PubMed ID: 16139999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of serum from patients with systemic scleroderma on collagen biosynthesis in the fibroblasts before and after administration of antilymphocyte globulin].
    Panasiuk AF; Lebedev DA; Gandzha IM; Iashchenko OB
    Ter Arkh; 1983; 55(2):113-5. PubMed ID: 6845188
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic sclerosis (scleroderma): etiology and pathogenesis--where are we today?].
    Stoll T; Brühlmann P; Fontana A; Gmür J; Michel BA
    Schweiz Med Wochenschr; 1994 Feb; 124(5):193-203. PubMed ID: 8128201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 1: pathogenesis].
    Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2006 Apr; 2(62):1052-7. PubMed ID: 16711150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.